Form 10-K Chemours Co For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250218/AP2ZB622ZM22DZA2222R2Z42ABNQZK22LD72
Filed on: February 18, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Metavesco's Epic Labor Reports July 2026 Revenue of $340,410, Up 280% Year-Over-Year
- Visuable Launches Summer Referral Campaign with Double Credits Incentive for Client Referrals
- Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
